March 2022

Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, is a Super-Speciality teaching and training Medical Institution, situated to the Southeast of Lucknow city on Lucknow-Raebareli Road, and is nearly 12 Km from the main (Charbagh) railway station, Lucknow Airport and city center (Hazratganj). From the railway station, private buses (route 3) run to the Institute at short intervals. Alternatively, pre-paid auto-rickshaws taxis are also available for travel to the Institute.

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Post : Manufacturing, Quality, Supply Chain Management Function, Technology Transfer

Founded in 1849, Pfizer is the worlds premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Zydus Cadila, a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients and animal healthcare products to wellness products, Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions.

Mepro Pharmaceuticals is a privately-owned pharmaceutical company with more than 3 decades of experience in providing quality healthcare. Headquartered in Mumbai, India, Mepro specializes in the development and manufacturing of niche and technically complex pharmaceutical products.

Although SARS-CoV-2 has taken the world by storm, it’s not the only coronavirus that can infect humans. But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally cause only mild disease. Now, researchers reporting in ACS Infectious Diseases have shown that infections with two different HCoVs don’t generate antibodies that effectively cross-react with SARS-CoV-2. So, prior infection with HCoVs is unlikely to protect against COVID-19 or worsen a SARS-CoV-2 infection through antibody-dependent enhancement (ADE), the researchers say.

Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that, for the first time, distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.

The findings, published today in the peer-reviewed Journal of the American College of Cardiology: Clinical Electrophysiology, have the potential to enhance prevention of sudden cardiac arrest unexpected loss of heart function—based on key risk factors identified in this study.

Secretary to the Government, Department of Health, Medical Education and Family Welfare, Jharkhand, Ranchi, letter number 163 (HSN), dated 21.05.2019 and letter number 669 (HS), dated 22.08.2019 and campaign director, National Rural Health Mission, Jharkhand,  Ranchi's letter no. 61 (MD), dated 08.01.2019, letter no. 1464 (MD), dated 13.08.2020 letter no. 1492 (MD).  Contract under N.R.H.M.

For the last six decades Central Government Health Scheme is providing comprehensive medical care to the Central Government employees and pensioners enrolled under the scheme. In fact CGHS caters to the healthcare needs of eligible beneficiaries covering all four pillars of democratic set up in India namely Legislature, Judiciary, Executive and Press.